TRUE Private Wealth Advisors’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-400
Closed -$11K 703
2020
Q2
$11K Hold
400
﹤0.01% 471
2020
Q1
$7K Buy
400
+341
+578% +$8.6K ﹤0.01% 488
2019
Q4
$1K Buy
+59
New +$1.47K ﹤0.01% 767
2019
Q3
Sell
-59
Closed -$1K 365
2019
Q2
$1K Buy
+59
New +$1.41K ﹤0.01% 754
2018
Q4
Sell
-4,299
Closed -$137K 424
2018
Q3
$137K Buy
+4,299
New +$139K 0.02% 308

Other funds holding EDIT

TRUE Private Wealth Advisors's EDIT Position: Q3 2020 in Review

TRUE Private Wealth Advisors sold out of Editas Medicine (EDIT) in Q3 2020, closing a stake of 400 shares — an estimated $11K sold.

TRUE Private Wealth Advisors first reported a position in EDIT in Q3 2018 and held it in 5 quarters. The position peaked at $137K in Q3 2018. 239 funds tracked by Wall St. Rank hold EDIT as of Q3 2020.

  • TRUE Private Wealth Advisors reported no remaining Editas Medicine position as of Q3 2020 after selling out during the quarter.
  • TRUE Private Wealth Advisors sold 400 Editas Medicine shares in Q3 2020, an estimated $11K.
  • TRUE Private Wealth Advisors first reported a position in Editas Medicine in Q3 2018 and held it in 5 quarters.
  • TRUE Private Wealth Advisors's Editas Medicine position peaked at $137K in Q3 2018.
  • 239 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2020.

Based on TRUE Private Wealth Advisors's 13F filing for Q3 2020, filed 9 Oct 2020.